Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-30

Clinical Trial Update: Effect of Inhaled Fentanyl on Dyspnea and Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD) [NA]

View source ↗

Summary

Clinical trial evaluating inhaled fentanyl for dyspnea and exercise tolerance in chronic obstructive pulmonary disease has completed with results posted in 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fentanyl (inhaled) (fentanyl)

Snippet

Sponsor: Queen's University | Conditions: Chronic Obstructive Pulmonary Disease | NA | Status: COMPLETED | Results posted: 2015-12-30